📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Solution structure of TT30, a novel complement therapeutic agent, provides insight into its joint binding to complement C3b and C3d. (2012)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jmb.2012.02.038

PubMed Identifier: 22387467

Publication URI: http://europepmc.org/abstract/MED/22387467

Type: Journal Article/Review

Volume: 418

Parent Publication: Journal of molecular biology

Issue: 3-4

ISSN: 0022-2836